Longeveron Inc. (LGVN) financial statements and ratios from SEC XBRL: revenue $0.0B (TTM), net margin -1893.6%, revenue growth 4.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $1.20M |
| Revenue (TTM) | $0.0B |
| Net Margin | -1893.6% |
| Return on Equity | -29.6% |
| Operating Margin (TTM) | -1881.7% |
| Current Ratio | 3.88 |
| Revenue Growth (YoY) | 4.5% |
| EPS Growth (YoY) | -44.1% |
| FCF Growth (YoY) | -7.5% |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.6 |
LGVN overview · LGVN earnings · LGVN KPIs · LGVN documents · LGVN ownership · LGVN peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.